Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma

by Jane E. Rogers, Jonathan D. Mizrahi, Lianchun Xiao, Chirayu Mohindroo, Rachna T. Shroff, Robert Wolff, Gauri R. Varadhachary, Milind M. Javle, Michael Overman, David R. Fogelman, Kanwal P. S. Raghav, Shubham Pant, Florencia McAllister
Published 2020-08-01

Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients

by Chirayu Mohindroo, Merve Hasanov, Jane E. Rogers, Wenli Dong, Laura R. Prakash, Seyda Baydogan, Jonathan D. Mizrahi, Michael J. Overman, Gauri R. Varadhachary, Robert A. Wolff, Milind M. Javle, David R. Fogelman, Michael T. Lotze, Michael P. Kim, Matthew H.G. Katz, Shubham Pant, Ching‐Wei D. Tzeng, Florencia McAllister
Published 2021-08-01

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.

by Awalpreet S Chadha, Heath D Skinner, Jillian R Gunther, Mark F Munsell, Prajnan Das, Bruce D Minsky, Marc E Delclos, Deyali Chatterjee, Huamin Wang, Marilyn Clemons, Geena George, Pankaj K Singh, Matthew H Katz, Jason B Fleming, Milind M Javle, Robert A Wolff, Gauri R Varadhachary, Christopher H Crane, Sunil Krishnan
Published 2016-01-01